U.S. Markets close in 5 hrs 25 mins

Ambien makers dispute Roseanne Barr's claim: 'Racism is not a known side effect'

Amid the condemnations that poured in about Roseanne Barr’s overtly racist tweet that likened Valerie Jarrett to if the “muslim brotherhood & planet of the apes had a baby,” it’s unlikely anyone could have predicted what would come next: The claim, from Barr herself, that Ambien is to blame. In a since-deleted tweet Tuesday night, hours after ABC canceled Roseanne, the 65-year-old reportedly said the sleep aid fueled her racist rant.

Roseanne Barr (Photo: Getty Images)

“It was 2 in the morning and I was Ambien tweeting-it was memorial day too-i went 2 far & do not want it defended-it was egregious Indefensible,” she reportedly wrote. “I made a mistake I wish I hadn’t but…don’t defend it please.” Before thanking her supporters Wednesday morning, Barr took the Ambien defense further, according to CNN. “Not giving excuses for what I did(tweeted),” she wrote. “But I’ve done weird stuff while on ambien—cracked eggs on the wall at 2am etc.”


By Wednesday morning, Ambien was the top trending topic on Twitter, where those who have used it insisted that it’s never caused them to spew racist remarks.


In an email to Yahoo Lifestyle, head of North America media relations for Sanofi, the maker of Ambien, aggressively disputed the notion that the popular sleep aid caused Barr’s racist remark.

“People of all races, religions and nationalities work at Sanofi every day to improve the lives of people around the world,” Ashleigh Koss told Yahoo Lifestyle. “While all pharmaceutical treatments have side effects, racism is not a known side effect of any Sanofi medication.”

Ambien, a medicine approved by the Food and Drug Administration in 1992, is one of the most widely used sleep aids in the U.S. Prescribed for “short-term treatment of insomnia characterized by difficulties with sleep initiation,” it has been shown to reduce sleeping difficulty. While the majority of those who do take it respond positively, Ambien, like many drugs, has a number of side effects. The most common include daytime drowsiness, headache, lightheadedness, upset stomach, and nausea.

None, it should be noted, include racism. The FDA does list “abnormal thinking” as another potential side effect, but notes that this happens in less than one percent of cases. When it does, individuals can experience things like “decreased inhibition,” “agitation,” and “depersonalization.” But even if racism fell into abnormal thinking (which it doesn’t), the FDA notes that a connection between unusual behavior and Ambien cannot necessarily be drawn.

“It can rarely be determined with certainty whether a particular instance of the abnormal behaviors listed above is drug induced, spontaneous in origin, or a result of an underlying psychiatric or physical disorder,” it reads. “Nonetheless, the emergence of any new behavioral sign or symptom of concern requires careful and immediate evaluation.”

Doctors and experts have taken to Twitter to further discredit Barr’s claim. Their expertise, along with the statement from Ambien’s makers, only serves to solidify the point: Racism doesn’t come from a drug.




Read more from Yahoo Lifestyle:

Follow us on InstagramFacebook, and Twitter for nonstop inspiration delivered fresh to your feed, every day.


  • Intel’s CEO resigns as information about a ‘past consensual relationship’ surfaces
    Finance
    TechCrunch

    Intel’s CEO resigns as information about a ‘past consensual relationship’ surfaces

    In a press release touting “another record year,” Intel dropped a a bombshell, announcing that CEO Brian Krzanich is resigning, amid revelations of a “past consensual relationship” with an employee. “Intel was recently informed that Mr. Krzanich had a past consensual relationship with an Intel employee,” the company notes in the release. “An ongoing investigation by internal and external counsel has confirmed a violation of Intel’s non-fraternization policy, which applies to all managers.

  • Business
    Investopedia

    Don't Overlook These 5 Things and Lose Retirement Income

    Having a comprehensive, integrated and personalized retirement income plan is key for retirees and pre-retirees. Today’s retirees need to look at all available resources they may have available to them in their household balance sheet, which includes not only maximizing assets but also reducing liabilities. Many retirees overlook simple solutions to create and protect retirement income because they follow the herd instead of getting individual recommendations from a retirement planning expert.

  • Michael Cohen wants Trump to pay his legal fees—and is reportedly willing to “give info” on him
    Politics
    Quartz

    Michael Cohen wants Trump to pay his legal fees—and is reportedly willing to “give info” on him

    Michael Cohen is very unhappy. Now, Cohen “associates” are telling the Wall Street Journal that the former Trump Organization lawyer is upset that the president isn’t paying his legal fees. The Trump campaign already paid nearly $230,000 to Cohen’s lawyers between October and January, to cover fees related to the Russia investigation.

  • Forget Johnson & Johnson: Here Are 2 Better Dividend Stocks
    Business
    Motley Fool

    Forget Johnson & Johnson: Here Are 2 Better Dividend Stocks

    If you own Johnson & Johnson (NYSE: JNJ) stock, there's a really good chance that you do so because of its dividend. The healthcare giant is a longtime favorite for income investors, in large part due to its sterling track record of 56 consecutive years of dividend increases. When it comes to dividends, I think investors should look to AbbVie (NYSE: ABBV) and Pfizer (NYSE: PFE) instead of J&J.

  • Business
    TheStreet.com

    5 Stocks That Are Screaming Buys Right Now

    Here we used TipRanks' stock screener to pinpoint the most compelling stocks right now. The Street is buzzing about Neurocrine's Ingrezza drug, the first FDA-approved treatment for adults with tardive dyskinesia. On its first quarter earnings call, Neurocrine updated the Street with respect to ongoing market penetration for Ingrezza.

  • Energy Transfer Partners Ranks Seventh Based on Analyst Ratings
    Business
    Market Realist

    Energy Transfer Partners Ranks Seventh Based on Analyst Ratings

    Which Midstream Stocks Do Analysts Prefer? (Continued from Prior Part) Analysts’ recommendations In terms of analysts’ ratings, Energy Transfer Partners (ETP), a diversified midstream company involved in almost all activities across the midstream value

  • Peter Fonda Apologizes for 'Vulgar' Barron Trump Tweet. 'I Went Way Too Far'
    News
    Time

    Peter Fonda Apologizes for 'Vulgar' Barron Trump Tweet. 'I Went Way Too Far'

    The actor later deleted the tweet and drew sharp rebukes from first lady Melania Trump and Donald Trump Jr. The two-time Oscar nominee, brother of Jane Fonda and son of Hollywood legend Henry Fonda said in a statement hours later that he was upset over children separated from their parents on the U.S.-Mexico border.

  • Why Sangamo Therapeutics Stock Is Spiking Today
    Business
    Motley Fool

    Why Sangamo Therapeutics Stock Is Spiking Today

    Shares of the gene therapy company Sangamo Therapeutics (NASDAQ: SGMO) rose by as much as 14.6% today on heavier than normal volume. Sangamo's shares are trading upward in sympathy with nearly all major gene therapy companies today. The long and short of it is that investors are clearly intrigued by the prospects of gene therapy to significantly improve the outlook for a whole range of deadly diseases.

  • Micron's quarterly results, forecasts beat on higher chip demand
    Business
    Reuters

    Micron's quarterly results, forecasts beat on higher chip demand

    By Vibhuti Sharma (Reuters) - Micron Technology Inc's (MU.O) third-quarter profit and current-quarter forecasts beat Street's expectations, as the chipmaker benefited from a strong demand for its memory chips used in computers and smartphones

  • Hard to believe this is bottom for General Electric
    Business
    CNBC Videos

    Hard to believe this is bottom for General Electric

    Jim Cramer explains why even General Electric's exit from the Dow Jones industrial average isn't the end of the industrial's painful turnaround.

  • Should You Buy Pfizer Inc (NYSE:PFE) At This PE Ratio?
    Business
    Simply Wall St.

    Should You Buy Pfizer Inc (NYSE:PFE) At This PE Ratio?

    Pfizer Inc (NYSE:PFE) is trading with a trailing P/E of 9.9x, which is lower than the industry average of 24x. Although some investors may jump to the conclusion that this is a great buying opportunity, understanding the assumptions behind the P/E ratio might change your mind. Today, I will explain what the P/E ratio is as well as what you should look out for when using it.

  • Business
    TheStreet.com

    Why Spotify Is the Ultimate Speculative Stock to Buy

    I scoffed at Spotify Technology when it went public in early April. I only bought the shares when the stock revisited it's previous lows in early May when TheStreet's founder Jim Cramer mentioned in passing how much he liked the service. I tried the

  • U.S. Tariff On Canadian Lumber Hits Home And Abroad
    Business
    Investing.com

    U.S. Tariff On Canadian Lumber Hits Home And Abroad

    Investing.com - While it's too soon to say how the Trump administration's bevy of new tariffs will impact various industries and the economy at large, a tariff on Canadian lumber import s imposed in late 2017 is certainly being felt by U.S. homebuilders.After a year of investigation, the U.S. imposed a tariff of 20.8% on imports of Canadian softwood lumber, a key ingredient in the construction of new homes.The tariff was meant to punish Canadian suppliers, who were judged to be selling below fair market value in the U.S., where they supply 95% of all imported lum ber. The homebuilders association says the tariff is the major reason behind record high lumber prices, which have jumped almost 60% since the tariff became a possibility in early 2017. And that's translated into a $9,000 increase in the average cost of a new single-family home.In one sense. the tariff has worked. Imports of Canadian lumber fell 15% in the first quarter from a year ago. The problem is U.S. production rose only 3% during that time. Experts say it will take years for the U.S. industry to ramp up production enough to compensate for the lost imports.

  • Business
    MarketWatch

    Why GE stock may be a buy after getting dumped from the Dow

    To understand why, look at what happened to IBM (IBM) in 1939, when it was kicked out of the Dow. Norman Fosback, the erstwhile head of the Institute for Economic Research, reported in his investment textbook “Stock Market Logic” that “the DJIA would today be more than twice its currently quoted level” had IBM not been kept out of the Average for those four decades — meaning the Dow currently would be at around 50,000. One measure of this comes from an analysis of the two dozen stocks that have been added or deleted from the Dow since 2000.

  • What’s Expected for State Street in Q2?
    Business
    Market Realist

    What’s Expected for State Street in Q2?

    What Lies Ahead for State Street? State Street’s Q2 EPS State Street (STT), set to report its second-quarter results on July 25, is expected to see its total fee revenue rise sequentially, primarily because of higher servicing and management fees. These

  • How Braava Will Be iRobot's Next Big Catalyst
    Business
    Motley Fool

    How Braava Will Be iRobot's Next Big Catalyst

    Shares of iRobot (NASDAQ: IRBT) have climbed more than 30% since the consumer robotics specialist announced first-quarter results in late April -- and with good reason. Both total revenue (up nearly 29%) and adjusted earnings per share (up 27%) comfortably

  • Koch Brothers' Groups Are Lobbying Congress to Curb President Trump's Authority on Tariffs
    Politics
    Time

    Koch Brothers' Groups Are Lobbying Congress to Curb President Trump's Authority on Tariffs

    The network backed by billionaire brothers Charles and David Koch is launching a six-figure ad campaign and sending letters to every member of Congress urging them to pass a bill that would curb President Donald Trump’s authority to impose tariffs. The network is urging Congress to support the Global Trade Accountability Act, legislation introduced by Utah Sen. Mike Lee at the beginning of Trump’s presidency. The bill would restore some of Congress’ constitutional authority to regulate foreign trade, requiring the President to seek approval from both houses of Congress before implementing any trade policy.

  • IP CFO resigns, top execs shuffle roles
    Business
    American City Business Journals

    IP CFO resigns, top execs shuffle roles

    After a little more than a year on the job, International Paper’s CFO has resigned. Glenn Landau, who joined Memphis-based International Paper Co. (IP) in 1991 as an engineer and worked his way up to the C-Suite, was named senior vice president and CFO in February 2017. On Wednesday, June 20, IP announced Landau was leaving the company “for personal reasons.” According to IP’s filing with the U.S. Securities and Exchange Commission, Landau’s departure was “not related to any disagreement with the company regarding any strategic, financial, accounting or other business matter.” Tim Nicholls will replace Landau in the role.

  • Tesla is suing the employee Elon Musk claimed committed sabotage against the company (TSLA)
    Finance
    Business Insider

    Tesla is suing the employee Elon Musk claimed committed sabotage against the company (TSLA)

    Tesla has filed a lawsuit against the employee CEO Elon Musk said committed sabotage against the company, Bloomberg first reported. On Monday, Musk said an employee had changed parts of  Tesla's manufacturing operating system code and sent "highly sensitive" company data to outside parties, according to an internal email acquired by CNBC.

  • Is It Too Late To Buy Skyworks Solutions Inc (NASDAQ:SWKS)?
    Business
    Simply Wall St.

    Is It Too Late To Buy Skyworks Solutions Inc (NASDAQ:SWKS)?

    Today we’re going to take a look at the well-established Skyworks Solutions Inc (NASDAQ:SWKS). The company’s stock saw a decent share price growth in the teens level on the NasdaqGS over the last few months. With many analysts covering the large-cap stock, we may expect any price-sensitive announcements have already been factored into the stock’s share price.

  • Analysts Raise Their 12-Month Target Price on Teva Pharmaceutical
    Business
    Market Realist

    Analysts Raise Their 12-Month Target Price on Teva Pharmaceutical

    On June 11, Leerink raised its 12-month target price on Teva from $13 to $16 while maintaining its “underperform” rating on the stock. Leerink analyst Ami Fadia revised the target prices to better reflect the improving dynamics of the company. Teva stock has risen ~14% over the last one month and registered YTD (year-to-date) stock price returns of ~28%.

  • Has iQiyi Stock Finally Hit Its Ceiling?
    Business
    InvestorPlace

    Has iQiyi Stock Finally Hit Its Ceiling?

    IQ stock churned in the low $20’s and abruptly took off, climbing north of $30 almost instantly, then $40. IQ may not be profitable like HUYA and SOGO, but given its stellar subscriber growth, it’s no wonder investors are excited.

  • Business
    TheStreet.com

    3 Warren Buffett Stock Picks That Could Be Perfect for Your Retirement Portfolio

    Warren Buffett, the chief executive of Berkshire Hathaway Inc. , has long been lauded as one of the greatest value investors of this lifetime. That makes his picks for Berkshire a solid pick for a retirement fund with a few years to grow. His preferences

  • Trade of the Day: Alibaba Stock Sets Up for Another Rally
    Finance
    InvestorPlace

    Trade of the Day: Alibaba Stock Sets Up for Another Rally

    Shares of Alibaba Group (NYSE:BABA) have largely trotted sideways over the past couple of weeks. The charts however now point out that BABA stock is setting up for another leg higher. For the year-to-date, BABA stock thus far is higher by close to 20%.

  • Judge denies Stormy Daniels request to restart case against Trump, Cohen
    News
    Reuters

    Judge denies Stormy Daniels request to restart case against Trump, Cohen

    In an order dated Tuesday, U.S. District Judge James Otero said the amount of media attention in the case was not a sufficient reason to reconsider the 90-day stay he had imposed in April. Daniels, whose real name is Stephanie Clifford, is suing to void a non-disclosure agreement under which Cohen paid her $130,000 not to discuss her alleged relationship with Trump in 2006 and 2007. In granting the stay, Otero had cited the potential overlap between Daniels' lawsuit and a separate criminal investigation by federal prosecutors in Manhattan that he said could result in Cohen's indictment.